公告本公司與韓國協和醱酵麒麟及韓國樂金化學簽署轉換與轉讓協議
1.事實發生日:113/12/31
2.公司名稱:韓國協和醱酵麒麟公司（Kyowa Hakko Kirin Korea Co., Ltd.，簡稱KKKR）
及韓國樂金化學(LG Chem，簡稱LGC）
3.與公司關係(請輸入本公司或子公司):無
4.相互持股比例:無
5.發生緣由:本公司與KKKR前於106/02簽署新藥拿百磷(Nephoxil)韓國市場授權與獨家
經銷合約(License and Exclusive Distribution Agreement，以下簡稱106年合約)；
及於112/05簽署供應合約(Master Supply Agreement，以下簡稱112年合約)。
113/08/27本公司接獲KKKR來函通知，因其母公司進行亞太地區組織架構與業務的調整，
因此來函終止前述合約。
因應上述，本公司與KKKR及LGC商談，由LGC繼續Nephoxil於韓國市場銷售，三方將簽署
轉換與轉讓協議(Assignment and Novation Agreement)，將前述106年合約及112年合約
中KKKR之所有權利與義務轉讓予LGC。
6.因應措施:本公司於董事會提案並通過，同意授權江宗明總經理簽署前述
轉換與轉讓協議。
7.其他應敘明事項(若事件發生或決議之主體係屬公開發行以上公司，本則重大訊息同時
符合證券交易法施行細則第7條第9款所定對股東權益或證券價格有重大影響之事項):
(1)LGC之公司介紹，請參閱下列連結：
https://www.lgchem.com/upload/file/introduce/2024_Introduction_of_LGChem_
EN.pdf
(2)KKKR母公司公布對亞太地區業務重組之新聞稿，請參閱下列連結:
https://www.kyowakirin.com/media_center/news_releases/2024/pdf/e20240801
_02.pdf
Announce Entry into Assignment and Novation Agreement with Kyowa Kirin Korea Co., Ltd. and LG Chem
1.Date of occurrence of the event:2024/12/31
2.Company name: Kyowa Hakko Kirin Korea Co., Ltd.(”KKKR”) and LG Chem (”LGC”)
3.Relationship to the Company (please enter ”head office” or ”subsidiaries”): NA
4.Reciprocal shareholding ratios: NA
5.Cause of occurrence: The Company signed a License and Exclusive Distribution Agreement with KKKR in February 2017 (“2017 Agreement”) and a Master Supply Agreement in May 2023 (“2023 Agreement”). The Company was notified on 2024/08/27 by KKKR that due to its parent company, Kyowa Kirin, planning a restructuring of operations in the APAC region, KKKR intended to terminate the agreements.
In response, the Company, KKKR and LGC entered into discussions to transfer the sales of Nephoxil in South Korea to LGC. Consequently, The Company, KKKR and LGC entered into an Assignment and Novation Agreement, under which all the rights and obligations from the 2017 Agreement and the 2023 Agreement will be transferred to LGC.
6.Countermeasures: The Company proposed at the Board of Directors meeting, and the Board approved the Assignment and Novation Agreement by authorizing the President Chiang, Chung-Ming to sign the aforementioned agreement.
7.Any other matters that need to be specified (the information disclosure also meets the requirements of Article 7, subparagraph 9 of the Securities and Exchange Act Enforcement Rules, which brings forth a significant impact on shareholders rights or the price of the securities on public companies.):
(1) For LGC company introduction, please refer to the following link: https://www.lgchem.com/upload/file/introduce/2024_Introduction_of_LGChem_EN.pdf
(2) For details of the news release on restructuring of APAC region business by KKKR’s parent company, please refer to the following link: https://www.kyowakirin.com/media_center/news_releases/2024/pdf/e20240801_02.pdf
回列表頁
請在這裡輸入標題
